The startup develops clinical decision support technology that continuously monitors maternal risk for postpartum hemorrhage (PPH) during labor and delivery. By providing predictive analytics hours before delivery, the technology enhances maternal safety and improves outcomes by identifying excessive blood loss, a leading cause of maternal mortality.
Funding
$210K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Postpartum hemorrhage (PPH), or excessive blood loss after childbirth, is a leading cause of maternal mortality. Current methods for monitoring PPH risk often rely on manual assessments and may not provide timely alerts, hindering proactive intervention.
Solution
The startup offers a clinical decision support system designed to continuously monitor maternal risk for PPH during labor and delivery. By leveraging predictive analytics, the technology aims to identify potential PPH cases hours before delivery, enabling clinicians to take proactive measures. The system analyzes various data points to provide a comprehensive risk assessment, enhancing maternal safety and improving outcomes associated with excessive blood loss. This allows for earlier intervention and potentially reduces the severity of PPH events.
Target Audience
The primary target audience includes obstetricians, nurses, and other healthcare professionals involved in maternal care during labor and delivery, as well as hospitals and healthcare systems focused on improving maternal safety and reducing PPH-related complications.
Features
- Continuous maternal risk monitoring during labor and delivery
- Predictive analytics to identify potential PPH cases hours before delivery
- Data-driven risk assessment based on relevant patient information
- Integration with existing clinical workflows and electronic health records (EHRs)
- Real-time alerts and notifications for timely intervention